SCHEMBL31452178

SCHEMBL31452178

CCCCNc1cncc(Cl)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 6/20 0.48
DRD2 P14416 5/20 0.48
HTR2A P28223 5/20 0.48
TLR8 Q9NR97 4/20 0.44
CDK2 P24941 3/20 0.43
KDM4E B2RXH2 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CNR2 P34972 1/20 0.41
HCAR3 P49019 2/20 0.41
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NR4A2 P43354 1/20 0.37
KDM6B O15054 1/20 0.36
KDM4C Q9H3R0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4628006 0.95 HRH1 (0.50) HRH1DRD2HTR2ATLR8CDK2
SCHEMBL6659258 0.86 HRH1 (0.50) HRH1DRD2HTR2ACDK2KDM4E
SCHEMBL12513367 0.84 HRH1 (0.45) HRH1DRD2HTR2ACDK2TSHR
SCHEMBL3509031 0.81 KDR (0.51) HRH1DRD2HTR2ACDK2
SCHEMBL31492959 0.80 HRH1 (0.44) HRH1DRD2HTR2ACDK2KDM4E
SCHEMBL11475156 0.80 HRH1 (0.41) HRH1DRD2HTR2ACDK2KDM4E
SCHEMBL22781931 0.79 HRH1 (0.48) HRH1DRD2HTR2ACDK2
SCHEMBL3505428 0.79 CYP2D6 (0.50) HRH1DRD2HTR2ACDK2KDM4E
SCHEMBL6469127 0.79 TLR8 (0.53) TLR8CDK2L3MBTL1HCAR3ALDH1A1
SCHEMBL6081553 0.79 HRH1 (0.44) HRH1DRD2HTR2ACDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250066341-A1 CYCLOHEXANE ACID DERIVATIVES AS LPA RECEPTOR INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2025-02-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250066341-A1 CYCLOHEXANE ACID DERIVATIVES AS LPA RECEPTOR INHIBITORS LPAR1, LPAR2, LPAR3 HRH1 231/4885DRD2 4208/4885HTR2A 1522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.